Surrogate Endpoints | Evidera
Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework | Nature Reviews Drug Discovery
Pulsatile energy consumption as a surrogate marker for vascular afterload improves with time post transcatheter aortic valve replacement in patients with aortic stenosis | Hypertension Research
Table I from Surrogate markers in HIV disease. | Semantic Scholar
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Diagnostics | Free Full-Text | Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
flowCAST-Basophils-Surrogate-Marker - Buhlmann Diagnostics Corp
UNDERSTANDING SCIENCE: SURROGATE MARKERS | Evidence Based Training
Surrogate Markers of Vision* | Download Table
The use of surrogate end points in cardiovascular disease and diabetes - The British Journal of Cardiology
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
Evaluation of a surrogate marker: validity and efficiency - Qu - 2013 - Statistics in Medicine - Wiley Online Library
attenuation parameter - List of Frontiers' open access articles
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity - Yongming Qu, 2013
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
PPT - Surrogate Markers and its role in the Drug Development Process PowerPoint Presentation - ID:533855
Surrogate Markers of Chronic Allograft Nephropathy in Man - ppt download
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
Surrogate Endpoints and Biomarkers | Basicmedical Key
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
JCM | Free Full-Text | Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a “Hyst-Oric” Change in Clinical Practice?
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
